IO Biotech

IO Biotech EBIT per Share

The EBIT per Share of IO Biotech (IOBT) as of Oct 19, 2026 is -1.44 USD. In the previous year, EBIT per Share was -1.39 USD — a change of 4.08% (lower).

EBIT per Share

-1.44USD

YoY

4.08%

Last updated:

EBIT per Share of IO Biotech is 2024 -1.44 USD. EBIT per Share of IO Biotech was 2023 -1.39 USD. It decreases by 4.08% lower compared to the previous year.

The IO Biotech EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2024
-1.44 USD
Jan 1, 2025 (e)
-1.21 USD
Jan 1, 2026 (e)
-1.16 USD
Jan 1, 2027 (e)
-0.99 USD
Jan 1, 2028 (e)
-1.27 USD
Jan 1, 2029 (e)
-0.34 USD
Jan 1, 2030 (e)
-0.13 USD
Jan 1, 2031 (e)
0.00 USD
The IO Biotech EBIT per Share history
YEAREBIT per ShareYoY
est0.00USD-100.00%
est-0.13USD-62.27%
est-0.34USD-73.19%
est-1.27USD+27.76%
est-0.99USD-14.60%
est-1.16USD-3.90%
est-1.21USD-16.13%
-1.44USD+4.08%
-1.39USD-44.00%
-2.48USD+54.65%
-1.60USD+82.44%
-0.88USD+493.24%
-0.15USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

IO Biotech Stock analysis

What does IO Biotech do? IO Biotech Inc, based in Copenhagen, Denmark, operates in the Health Care sector, specializing in Biotechnology. The company develops immune modulating cancer therapies using its T-win technology platform, focusing on disrupting tumor-induced immunosuppression. Its lead product candidate, IO102-IO103, targets immunosuppressive proteins like IDO and PD-L1. Founded as a spin-off from the National Cancer Center Immune Therapy at Herlev University Hospital, IO Biotech has 57 employees and is listed on the stock exchange since November 5, 2021. IO Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IO Biotech stock

EBIT per Share of IO Biotech is -1.44 USD in 2024.

EBIT per Share of IO Biotech changed from -1.39 USD to -1.44 USD, representing a 4.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share IO Biotech since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — IO Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — IO Biotech